Episodes

  • Optimizing Outcomes in Myeloma

    Optimizing Outcomes in Myeloma
    Mar 24 2026

    Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC

    Recorded on March 10, 2026


    Amy Pierre, MSN, ANP-BC
    Senior Clinical Director, Research Oncology, Flatiron Health
    Nurse Practitioner, Memorial Sloan Kettering Cancer Center
    New York, NY
    Peter Voorhees, MD
    Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder
    Program, Department of Hematologic Oncology and Blood Disorders
    Levine Cancer Institute
    Charlotte, NC
    Professor, Cancer Medicine
    Wake Forest University School of Medicine
    Winston-Salem, NC
    In this episode, Dr. Peter Voorhees from the Levine Cancer Institute and Amy Pierre, MSN, RN, ANP BC from Flatiron Health and Memorial Sloan Kettering, break down the evolving landscape of myeloma, from early signs and diagnostic criteria to frontline therapy, transplant decisions, and T- cell redirecting therapies. They explore real world challenges in survivorship, treatment toxicity, and disparities in access to advanced therapies, offering practical insights to help care teams support patients more effectively. Tune in for an informative and forward looking discussion shaping the future of myeloma management.

    Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show more Show less
    40 mins
  • Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology

    Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology
    Mar 3 2026

    Matthew Kutny, MD, University of Alabama, Birmingham, AL, Julie Guillot, Pediatric AML parent, global advocate, and Blood Cancer United Volunteer, and Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC

    Recorded on February 19, 2026


    Matthew Kutny, MD
    Professor of Pediatrics
    Director, Leukemia, Lymphoma and Histiocytosis Program
    Director, Pediatric Clinical Trials Office
    Institutional Principal Investigator, Children’s Oncology Group (NCI NCTN)
    Pediatric Hematology and Oncology
    University of Alabama at Birmingham
    Birmingham, AL
    Julie Guillot
    Pediatric AML parent, global advocate, and Blood Cancer United Volunteer
    Kelly Laschinger, MSN, RN, CPNP, CPHON
    Director, Clinical Trial Support Center
    Blood Cancer United
    Washington, DC
    In this episode, Dr. Matthew Kutny from the University of Alabama, and Kelly Laschinger, CPNP and Julie Guillot from Blood Cancer United, break down what clinicians and families need to know about Expanded Access (EA), also known as Compassionate Use, in treating pediatric oncology patients. They clarify key terms, outline when EA should be considered, and walk through how the process works in real-world practice. Their conversation also addresses common barriers, from institutional requirements to sponsor approval, and highlights how pediatric care teams and advocates can work together to navigate them. Tune in for an informative and insightful conversation to help healthcare professionals better understand and utilize Expanded Access!

    Blood Cancer United Resources:

    • Clinical Trial Support Center
    • Information Resource Center
    • Dare to Dream Project
    • Pediatric Acute Leukemia Master Clinical Trial (PedAL)

    Mentioned on this episode:

    • Project Facilitate

    This episode is supported by the Tom Reich Educational Endowment Fund.
    Show more Show less
    40 mins
  • What’s New and What’s Next in CLL

    What’s New and What’s Next in CLL
    Feb 17 2026

    Brad Kahl, MD, Siteman Cancer Center, St. Louis MO

    Recorded on January 27, 2026


    Brad Kahl, MD
    Professor of Medicine
    Division of Oncology, Department of Medicine
    Washington University School of Medicine
    Director, Lymphoma Program
    Siteman Cancer Center
    St. Louis, MO
    In this episode, join Dr. Brad Kahl, Director of the Lymphoma Program at the Siteman Cancer Center in St. Louis, Missouri, as he delivers a concise and practical overview of chronic lymphocytic leukemia (CLL), from initial disease presentation to key diagnostic considerations. Dr. Kahl discusses the prognostic value of cytogenetic testing and its impact on treatment selection and reviews currently approved therapeutic options alongside notable updates from the latest American Society of Hematology (ASH) meeting. He also examines emerging agents and ongoing clinical trials that are shaping the future CLL treatment landscape. The conversation further explores strategies for managing side effects, addressing complications, and supporting patients and caregivers. Tune in for this timely and informative discussion!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show more Show less
    39 mins
  • Guiding Fertility Care for Adolescents and Young Adults

    Guiding Fertility Care for Adolescents and Young Adults
    Feb 4 2026

    Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA

    Recorded on January 20, 2026


    Pam Simon, MSN, CPNP, CPON
    Nurse Practitioner & Program Manager
    Stanford Adolescent and Young Adult Cancer Program (SAYAC)
    Palo Alto, CA
    H. Irene Su, MD MSCE
    Professor
    Reproductive Endocrinology and Infertility Fellowship Director
    Division of Reproductive Endocrinology and Infertility
    Co-Director, Center for Obstetrics and Gynecology Research Innovations
    Department of Obstetrics, Gynecology and Reproductive Sciences
    Director, Moores Cancer Center Leadership Academy
    University of California San Diego
    San Diego, CA
    In this episode, we’re joined by Dr. Irene Su, Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego, and Pam Simon, Nurse Practitioner and Program Manager of the Stanford Adolescent and Young Adult (AYA) Cancer Program at Stanford Medicine. They discuss fertility risk across treatment types, approaches to fertility preservation and reproductive survivorship planning, insurance and access considerations, and the cultural and sociodemographic factors that shape care. They also share strategies to support shared decision-making and promote psychosocial well being for AYA patients and survivors. Tune in for practical insights to strengthen your approach to fertility care for AYAs.

    Mentioned on this episode:

    • OncofertilityRisk.com
    • The Alliance for Fertility Preservation

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show more Show less
    38 mins
  • Building Resilience: Burnout & Compassion Fatigue Tools for HCPs

    Building Resilience: Burnout & Compassion Fatigue Tools for HCPs
    Jan 23 2026

    Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT

    Recorded on January 8, 2026


    Chelsey Winegar, LCSW, MBA
    Manager of Oncology Services
    Intermountain Health
    Murray, UT
    Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences between burnout and compassion fatigue, and why understanding both is essential for the well being of healthcare professionals and the patients they serve. Chelsey shares practical strategies for recognizing early warning signs, monitoring staff wellness, and building supportive, stigma free environments. The episode also highlights resources and education to help clinicians maintain resilience in demanding clinical settings. Listen in to learn more today!

    Mentioned on this episode:

    • Trauma Stewardship

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show more Show less
    37 mins
  • Key Insights from Attending ASH 2025

    Key Insights from Attending ASH 2025
    Jan 13 2026

    Lore Gruenbaum, PhD, Blood Cancer United, Washington, DC

    Recorded on December 18, 2025


    Lore Gruenbaum, PhD
    Chief Scientific Officer & Senior Vice President of Research
    Blood Cancer United
    Washington, DC
    Join Dr. Lore Gruenbaum, Chief Scientific Officer and Senior Vice President of Research at Blood Cancer United, to provide practice-changing data in hematologic malignancies from the 67th American Society of Hematology (ASH) Annual Meeting. Explored are breakthroughs in multiple myeloma, AML, CLL, and advances in cell therapy. Discussion also covers the growing use of artificial intelligence to accelerate precision medicine, spotlighting the Blood Cancer United Beat AML® Master Clinical Trial as a model for AI-driven trial design and real-time clinical decision-making. Tune in today for the key takeaways you need to know!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Resources for Patients
    Show more Show less
    34 mins
  • Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know

    Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
    Dec 17 2025

    Raymond Mailhot, MD, MPH, University of Miami, Miami, FL

    Recorded on December 2, 2025


    Raymond Mailhot, MD, MPH
    Department of Radiation Oncology
    University of Miami
    Miami, FL
    Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes!

    Additional Blood Cancer United Resources:

    • Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
    • Blood Cancer United Medical Debt Case Management Program for Patients
    • Blood Cancer United Additional Resources for Patients
    Show more Show less
    31 mins
  • Hairy Cell Leukemia: Strategies for Improved Patient Outcomes

    Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
    Nov 20 2025

    Paul J. Hampel, MD, Mayo Clinic, Rochester, MN

    Recorded on November 4, 2025


    Paul J. Hampel, MD
    Assistant Professor of Medicine
    Division of Hematology, Department of Medicine
    Mayo Clinic
    Rochester, MN
    In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.

    Show more Show less
    40 mins